Scienture Holdings Past Earnings Performance
Past criteria checks 0/6
Scienture Holdings's earnings have been declining at an average annual rate of -292.7%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been declining at an average rate of 152.2% per year.
Key information
-292.7%
Earnings growth rate
-245.9%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | -152.2% |
| Return on equity | -12.0% |
| Net Margin | 2,916.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Scienture Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 0 | -10 | 8 | 3 |
| 30 Jun 24 | 0 | -7 | 6 | 2 |
| 31 Mar 24 | 0 | -5 | 3 | 2 |
| 31 Dec 23 | 1 | -2 | 1 | 2 |
| 31 Dec 22 | 0 | -4 | 1 | 3 |
Quality Earnings: SCNX is currently unprofitable.
Growing Profit Margin: SCNX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if SCNX's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare SCNX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SCNX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: SCNX has a negative Return on Equity (-12.04%), as it is currently unprofitable.